Last updated 5 days ago
A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn
300 patients around the world
Available in Spain, Argentina, United States
Merck Sharp & Dohme LLC
2Research sites
300Patients around the world
This study is for people with
Hypercholesterolemia
Requirements for the patient
From 18 Years
All Gender
Medical requirements
SponsorMerck Sharp & Dohme LLC
Conditions
Hypercholesterolemia
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06450366
